Home › beta-Thalassemia › New York
beta-Thalassemia clinical trials in New York
5 studies for beta-Thalassemia are looking for participants at sites in New York.
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
- New York Presbyterian Hospital, New York
RecruitingPhase 2
Ages 6 to 17 · All sexes · Updated Jul 10, 2026 · NCT04143724A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre
RecruitingPhase 2
Ages 2 to 50 · All sexes · Updated Jun 3, 2026 · NCT05736419Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
RecruitingPhase 3
Ages 12 to 35 · All sexes · Updated Mar 23, 2026 · NCT05477563AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- New York Medical College, Valhalla
RecruitingPhase 2
1 Day – 30 Years · All sexes · Updated Aug 8, 2025 · NCT04099966A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
- Cohen Children's Medical Center, New Hyde Park
RecruitingObservational study
All ages · All sexes · Updated Feb 11, 2025 · NCT06271512From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.